These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11759615)

  • 1. Professional considerations for providing mifepristone-induced abortion.
    Fielding SL; Lee SS; Schaff EA
    Nurse Pract; 2001 Nov; 26(11):44-54. PubMed ID: 11759615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone for medical abortion. Exploring a new option for nurse practitioners.
    Taylor D; Hwang AC
    AWHONN Lifelines; 2003 Dec-2004 Jan; 7(6):524-9. PubMed ID: 14753095
    [No Abstract]   [Full Text] [Related]  

  • 3. Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion.
    Simmonds KE; Beal MW; Eagen-Torkko MK
    J Midwifery Womens Health; 2017 May; 62(3):348-352. PubMed ID: 28632953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early abortion. Update and implications for midwifery practice.
    Narrigan D
    J Nurse Midwifery; 1998; 43(6):492-501. PubMed ID: 9871382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion.
    Gold M; Chong E
    Contraception; 2015 Sep; 92(3):194-6. PubMed ID: 26093187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
    Mackenzie SJ; Yeo S
    J Nurse Midwifery; 1997; 42(2):86-90. PubMed ID: 9107115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical abortion practices: a survey of National Abortion Federation members in the United States.
    Wiegerinck MM; Jones HE; O'Connell K; Lichtenberg ES; Paul M; Westhoff CL
    Contraception; 2008 Dec; 78(6):486-91. PubMed ID: 19014795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone in South Australia -- the first 1343 tablets.
    Mulligan E; Messenger H
    Aust Fam Physician; 2011 May; 40(5):342-5; quiz 351-2. PubMed ID: 21597558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of first-trimester abortion.
    Contraception; 2014 Mar; 89(3):148-61. PubMed ID: 24795934
    [No Abstract]   [Full Text] [Related]  

  • 13. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal.
    Rocca CH; Puri M; Shrestha P; Blum M; Maharjan D; Grossman D; Regmi K; Darney PD; Harper CC
    PLoS One; 2018; 13(1):e0191174. PubMed ID: 29351313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are US health professionals likely to prescribe mifepristone or methotrexate?
    Koenig JD; Tapias MP; Hoff T; Stewart FH
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):155-60. PubMed ID: 10846327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?
    Shannon C; Winikoff B
    Womens Health (Lond); 2008 Mar; 4(2):107-11. PubMed ID: 19072508
    [No Abstract]   [Full Text] [Related]  

  • 20. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.
    Clark WH; Gold M; Grossman D; Winikoff B
    Contraception; 2007 Apr; 75(4):245-50. PubMed ID: 17362700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.